Search Within

Ai Ni

Formats
  1. Journal Article (51)
  2. Meeting Abstract (48)
Groups
  1. Biostatistics Service (99)
  2. Epidemiology and Biostatistics (99)
  3. Department of Medicine (96)
  4. Solid Tumor Oncology Division (70)
  5. GSK Faculty (58)
  6. Department of Pathology and Laboratory Medicine (56)

More Groups

People
  1. Charles Rudin (34)
  2. Mark Kris (34)
  3. Gregory Riely (29)
  4. Andrew Zelenetz (26)
  5. Marc Ladanyi (26)
  6. Matthew Hellmann (26)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2021 (2)
  4. 2020 (7)
  5. 2019 (24)
  6. 2018 (32)

More Years

Publications
  1. Journal of Clinical Oncology (26)
  2. Blood (11)
  3. Hematological Oncology (8)
  4. Journal of Thoracic Oncology (7)
  5. Modern Pathology (6)
  6. Clinical Cancer Research (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (28)
  2. American Society of Hematology (11)
  3. Elsevier Inc. (10)
  4. Wiley Blackwell (10)
  5. American Association for Cancer Research (7)
  6. Nature Research (6)

More Publishers

Results (99)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tumor mutation burden and efficacy of targeted therapy in patients with EGFR mutant lung cancers
    Meeting Abstract

    Offin, M. D.; Rizvi, H.; Tenet, M.; Ni, A.; Sanchez Vega, F.; Kris, M. G.; Rudin, C. M.; Riely, G. J.; Yu, H. A.; Hellmann, M. D.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Circulating tumor DNA in advanced lung cancers: A prospective evaluation of matched therapy and shedding detection
    Meeting Abstract

    Offin, M. D.; Stephens, D.; Sabari, J. K.; Makhnin, A.; Myers, M.; Ni, A.; Pavlakis, N.; Clarke, S. J.; Tandon, N.; Datta, S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Frequency of brain metastases and outcomes in patients with HER2-, KRAS-, and EGFR-mutant lung cancers
    Meeting Abstract

    Kris, M. G.; Offin, M. D.; Feldman, D. L.; Ni, A.; Lai, W. C. V.; Arbour, K. C.; Daras, M.; Pentsova, E.; DeAngelis, L. M.; Beal, K.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • PD-L1 expression, tumor mutation burden and response to immune checkpoint blockade in patients with HER2-mutant lung cancers
    Meeting Abstract

    Lai, W. C. V.; Feldman, D. L.; Buonocore, D. J.; Brzostowski, E. B.; Rizvi, H.; Plodkowski, A. J.; Ni, A.; Sabari, J. K.; Offin, M. D.; Kris, M. G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Deleterious effect of baseline steroids on efficacy of PD-(L)1 blockade in patients with NSCLC
    Meeting Abstract

    Arbour, K. C.; Mezquita, L.; Long, N.; Rizvi, H.; Auclin, E.; Ni, A.; Bernal, G. M.; Chaft, J. E.; Ferrara, R.; Lai, W. C. V.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Risk model for overall survival for patients with relapsed/refractory chronic lymphocytic leukemia: Validated for patients on ibrutinib, idelalisib, venetoclax, or chemoimmuniotheraphy
    Meeting Abstract

    Soumerai, J. D.; Ni, A.; Darif, M.; Londhe, A.; Xing, G.; Mun, Y.; Kay, N. E.; Shanafelt, T. D.; Chaffee, K. G.; Furman, R. R.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • VISTA is highly expressed in malignant pleural mesothelioma (MPM) and independent of PD-L1 expression
    Meeting Abstract

    Zauderer, M.; Muller, S.; Lai, W.; Ni, A.; Jungbluth, A.; Ginsberg, M.; Daly, R.; Hellmann, M.; Ladanyi, M.; Sauter, J.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • MET exon 14-altered lung cancers: Central nervous system (CNS) metastases and patterns of CNS progression on MET inhibition
    Meeting Abstract

    Offin, M.; Dienstag, J.; Wilkins, O.; Sabari, J.; Ni, A.; Feldman, D.; Van Voorthuysen, M.; Suzawa, K.; Yu, H.; Riely, G.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Concurrent mutations in STK11 and KEAP1 is associated with resistance to PD-(L)1 blockade in patients with NSCLC despite high TMB
    Meeting Abstract

    Arbour, K.; Shen, R.; Plodkowski, A.; Rizvi, H.; Ni, A.; Long, N.; Halpenny, D.; Sanchez-Vega, F.; Rudin, C.; Riely, G.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Phase I/II clinical trial of ibrutinib and buparlisib in relapsed/refractory diffuse large B-cell lymphoma, mantle cell lymphoma, and follicular lymphoma
    Meeting Abstract

    Batlevi, C. L.; De Frank, S.; Stewart, C.; Hamlin, P. A.; Matasar, M. J.; Gerecitano, J. F.; Moskowitz, A. J.; Hamilton, A. M.; Zelenetz, A. D.; Drullinsky, P.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save